Patents Assigned to Ecstasy LLC
  • Amines for use as sigma receptor modulators
    Patent number: 11945810
    Abstract: The present invention discloses a number of polycyclic amines that are useful as opioid receptor modulators. The compounds of the invention are useful in both therapeutic and diagnostic methods, including for treating pain, neurological disorders, cardiac disorders, bowel disorders, drug and alcohol addiction, drug overdose, urinary disorders, respiratory disorders, sexual dysfunction, psoriasis, graft rejection or cancer.
    Type: Grant
    Filed: January 2, 2023
    Date of Patent: April 2, 2024
    Assignee: Ecstasy LLC
    Inventors: Xiaodong Wang, Baizhi Li
  • Polycyclic amines as sigma receptor modulators
    Patent number: 11584765
    Abstract: The present invention provides a genus of polycyclic amines that are useful as opioid receptor modulators. The compounds of the invention are useful in both therapeutic and diagnostic methods, including for treating pain, neurological disorders, cardiac disorders, bowel disorders, drug and alcohol addiction, drug overdose, urinary disorders, respiratory disorders, sexual dysfunction, psoriasis, graft rejection or cancer.
    Type: Grant
    Filed: May 28, 2020
    Date of Patent: February 21, 2023
    Assignee: ECSTASY LLC
    Inventors: Xiaodong Wang, Hua Zhong
  • Polycyclics as sigma receptor modulators
    Patent number: 11548879
    Abstract: The present invention discloses a number of polycyclic amines that are useful as opioid receptor modulators. The compounds of the invention are useful in both therapeutic and diagnostic methods, including for treating pain, neurological disorders, cardiac disorders, bowel disorders, drug and alcohol addiction, drug overdose, urinary disorders, respiratory disorders, sexual dysfunction, psoriasis, graft rejection or cancer.
    Type: Grant
    Filed: June 30, 2021
    Date of Patent: January 10, 2023
    Assignee: ECSTASY LLC
    Inventors: Xiaodong Wang, Baizhi Li
  • Anhydrous depigmenting compositions comprising phenolic compounds
    Patent number: 9687433
    Abstract: The present invention is relates to a novel anhydrous dermatological depigmenting compositions comprising a phenolic compound, and methods of making and using the same.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: June 27, 2017
    Assignee: Ecstasy LLC
    Inventors: Xiaodong Wang, Hua Zhong